CN1857544A - Chinese medicine preparation for treating hyperosteogeny - Google Patents
Chinese medicine preparation for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1857544A CN1857544A CNA2005101131805A CN200510113180A CN1857544A CN 1857544 A CN1857544 A CN 1857544A CN A2005101131805 A CNA2005101131805 A CN A2005101131805A CN 200510113180 A CN200510113180 A CN 200510113180A CN 1857544 A CN1857544 A CN 1857544A
- Authority
- CN
- China
- Prior art keywords
- hyperosteogeny
- radix
- medicine
- myrrha
- olibanum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of externally applied medicine for treating cervical vertebra proliferation, lumber vertebra proliferation, protrusion of lumbar intervertebral disc and other hyperosteogeny. The externally applied medicine is prepared with camphor and other 12 kinds of Chinese medicinal materials, and through frying partial material, vinegar pre-treatment of partial material and other steps. The present invention has unique recipe and obvious curative effect.
Description
Technical field
The present invention relates to a kind of main treatment with hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis etc. is main external used medicine.Be to be the medicament of feedstock production with the Chinese herbal medicine specifically.
Background technology
Motherland's medical science has such theory to cervical spondylosis, scapulohumeral periarthritis etc.: pain is then obstructed, and general rule is not bitterly.Nothing is cold painless, and the pain happiness was sent out in winter, two seasons of spring.Wind, cold, wet, evil four gas are assorted forms numbness to closing.Its therapeutic scheme mainly be dispel the wind, dehumidifying, cold relieving, and prescription is oral medicine mostly, medicine for external use also is no lack of its minority recently.
The external used medicine of state's internal therapy cervical vertebra, hyperosteogeny, scapulohumeral periarthritis is numerous at present, chooses two kinds of popular ointment now to as directed.One: " DONGFANG HUOXUE GAO " that east, Jinan pharmaceutical factory produces, (the accurate word Z37020953 of traditional Chinese medicines) waits 27 Chinese prescriptions of distinguishing the flavor of to form with " Radix Aconiti, Radix Aconiti Kusnezoffii, Flos Carthami, Rhizoma Et Radix Notopterygii, Scorpio ", its " function cure mainly into, expelling wind and cold, relaxing muscles and tendons and activating QI and blood in the collateral; Be used for shoulder arm lumbago and skelalgia, numb limbs and tense tendons due to the anemofrigid-damp arthralgia ".Its two: " dog skin plaster " that Beijing joint-stock company of Tongrentang produces, (the accurate word Z11020207 of traditional Chinese medicines) wait 26 Chinese prescriptions of distinguishing the flavor of to form with " Radix Aconiti, Radix Angelicae Pubescentis, Fructus Chaenomelis, Oleum Terebinthinae, Borneolum Syntheticum ", " function cures mainly and is expelling wind and cold, promoting blood circulation and stopping pain for it.Be used for wind-cold damp pathogen, traumatic injury, gather mass in the abdomen." major defect of its existence is: for hyperosteogeny, hyperosteogeny, diseases such as prolapse of lumbar intervertebral disc, it is slow to take effect, (just can take effect about two weeks sometimes), efficiency time is not long, easily recurs.Both incur loss through delay conditions of patients, increased financial burden again.Can accept a kind of medical product but still be no lack of for the Most patients masses.
Summary of the invention
The object of the present invention is to provide a kind of pure Chinese medicine topical agent, it is for hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, and scapulohumeral periarthritis etc. provide a kind of convenience, topical agent effective, without any side effects.This medicament called after skeletal slaking powder.
It is relevant theoretical based on motherland's medical science that technical solution of the present invention is the inventor, thinks that disease exopathogenic factor such as hyperosteogeny has relation with affection of exogenous wind-cold, damp, and modal and trauma history has relation, endogenous cause of ill and kidney, liver two void, and deficient qi and blood has relation.So Therapeutic Principle of the present invention is: drive that stagnation resolvation is swollen, hard masses softening and resolving, promoting blood circulation and stopping pain.Feature at diseases such as hyperosteogeny, waist neck hypertrophy, relevant theoretical in conjunction with motherland's medical science, drawn blood stasis removing in motherland's medicine selectively, invigorated blood circulation, the prescription elite of collateral dredging, sum up clinical experience for many years, filter out scientifically prescription of Chinese herbal medicine evident in efficacy, develop the medicine for external use skeletal slaking powder of diseases such as specially controlling hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis.It is treated targetedly for hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis etc., reaches ideal curative effect.
Skeletal slaking powder of the present invention is made (consumption is a weight portion) by the following traditional Chinese medicines component
Camphora 2.5～3.5 Sanguis Draxonis 1.5～2.5 Radix Notoginsengs 1.5～2.5
Olibanum 0.5～1.5 Myrrha 0.5～1.5 Flos Carthami 0.1～0.6
Rhizoma Drynariae 0.5～1.5 beautiful osmanthus 0.1～0.6 Pollen Typhae 0.5～1.5
Rhizoma Chuanxiong 0.5～1.5 Radix Angelicae Sinensis 0.5～1.5 Eupolyphaga Seu Steleophaga 1.5～2.5
Lignum Dalbergiae Odoriferae 0.5～1.5
Skeletal slaking powder optimum weight of the present invention (part) proportioning is:
Camphora 3 Sanguis Draxonis 2 Radix Notoginsengs 2 Eupolyphaga Seu Steleophagas 2
Olibanum 1 Myrrha 1 Flos Carthami 0.5 Rhizoma Drynariae 1
Beautiful osmanthus 0.5 Pollen Typhae, 1 Rhizoma Chuanxiong, 1 Radix Angelicae Sinensis 1
Lignum Dalbergiae Odoriferae 1
The preparation method of making skeletal slaking powder of the present invention by above-mentioned each component is:
1, fries Olibanum, Myrrha with cast iron pan earlier;
2, back vinegar Radix Angelicae Sinensis (parched), Rhizoma Chuanxiong;
3,, preserve with vial or porcelain vase again the pulverization of putting together of other Chinese herbal medicine in the prescription;
When 4, the patient uses, add market general Dieda plaster for curing traumatic injury on sale and mix well use.
Skeletal slaking powder of the present invention has the following advantages:
Skeletal slaking powder is made up of traditional secret recipe prescriptions such as " Cortex torricelliae tiliifoliaes ", has that the stagnation resolvation of driving is swollen, an effect of dredge the meridian passage, hard masses softening and resolving, promoting blood circulation and stopping pain.Because it is a medicine for external use,, significant curative effect is arranged for diseases such as hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis so dosage prescription relatively more for oral administration wants big 1-2 doubly, have instant effect: 1.5～4.8 hours take effect, that is: pain disease is eliminated, and other various symptoms are alleviated thereupon; Relapse rate is low, and general being difficult for recurs, even indivedual recurrence, its symptom before alleviates, and many cases on probation, does not see the case that any toxic and side effects reaction is arranged.Easy to use, an adhesive plaster can stick the affected part in the patient at any time, everywhere; If massage treatment next day of auxilliary again, curative effect is more obvious.
The skeletal slaking powder medical effect sees following table for details
| Title | The example number | Cure number | Significant figure | Invalid number | Effective percentage % |
| Hyperosteogeny | 50 | 50 | 50 | 0 | 100 |
| Hyperosteogeny | 20 | 18 | 19 | 1 | 95 |
| Prolapse of lumbar intervertebral disc | 90 | 80 | 82 | 8 | 90 |
| Scapulohumeral periarthritis | 10 | 9 | 1 | 90 |
The specific embodiment
Embodiment.Executing of pain disease such as hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis are controlled.
1, the composition of medicine and proportioning
Camphora 3g Sanguis Draxonis 2g Radix Notoginseng 2g
Eupolyphaga Seu Steleophaga 2g Olibanum 1g Myrrha 1g
The beautiful osmanthus 0.5g of Flos Carthami 0.5g Rhizoma Drynariae 1g
Pollen Typhae 1g Rhizoma Chuanxiong 1g Radix Angelicae Sinensis 1g
Lignum Dalbergiae Odoriferae 1g
2, preparation method and use
Earlier with cast iron pan parch Olibanum, Myrrha, the back is with vinegar Radix Angelicae Sinensis (parched), Rhizoma Chuanxiong, the pulverization of putting together of other Chinese herbal medicine in the prescription, adorns in the pouch, and preserves with vial or porcelain vase then.Its using method is: spread out with the Dieda plaster for curing traumatic injury that sell in market, add this medicamental pulverata, the softening use of mixing well of heating; One plaster (available 3-5 days) is a course of treatment, general 3-5 course of treatment.
Claims (2)
1, a kind of medicine for external use for the treatment of diseases such as hyperosteogeny, hyperosteogeny, prolapse of lumbar intervertebral disc, scapulohumeral periarthritis is characterized in that the medicament that it is made by following weight proportioning raw material.
Camphora 2.5～3.5 Sanguis Draxonis 1.5～2.5 Radix Notoginsengs 1.5～2.5
Olibanum 0.5～1.5 Myrrha 0.5～1.5 Flos Carthami 0.1～0.6
Rhizoma Drynariae 0.5～1.5 beautiful osmanthus 0.1～0.6 Pollen Typhae 0.5～1.5
Rhizoma Chuanxiong 0.5～1.5 Radix Angelicae Sinensis 0.5～1.5 Lignum Dalbergiae Odoriferae 0.5～1.5
Eupolyphaga Seu Steleophaga 1.5～2.5.
2, medicament according to claim 1, wherein each raw material weight proportioning is:
Camphora 3g Sanguis Draxonis 2g Radix Notoginseng 2g Eupolyphaga Seu Steleophaga 2g
Olibanum 1g Myrrha 1g Flos Carthami 0.5g Rhizoma Drynariae 1g
Beautiful osmanthus 0.5g Pollen Typhae 1g Rhizoma Chuanxiong 1g Radix Angelicae Sinensis 1g
Lignum Dalbergiae Odoriferae 1g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101131805A CN100409877C (en) | 2005-10-16 | 2005-10-16 | Chinese medicine preparation for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101131805A CN100409877C (en) | 2005-10-16 | 2005-10-16 | Chinese medicine preparation for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1857544A true CN1857544A (en) | 2006-11-08 |
| CN100409877C CN100409877C (en) | 2008-08-13 |
Family
ID=37296532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101131805A Expired - Fee Related CN100409877C (en) | 2005-10-16 | 2005-10-16 | Chinese medicine preparation for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100409877C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104095973A (en) * | 2014-07-30 | 2014-10-15 | 吴英娥 | Externally-used traditional Chinese medicine composition for treating hyperostosis and preparation of externally-used traditional Chinese medicine composition |
| CN104324136A (en) * | 2014-11-14 | 2015-02-04 | 马朝栋 | Traditional Chinese medicine unguent for treating osteoproliferation and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1059096C (en) * | 1996-01-05 | 2000-12-06 | 李振 | Method of preparing medicated wine for treating injury and setting bone |
-
2005
- 2005-10-16 CN CNB2005101131805A patent/CN100409877C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104095973A (en) * | 2014-07-30 | 2014-10-15 | 吴英娥 | Externally-used traditional Chinese medicine composition for treating hyperostosis and preparation of externally-used traditional Chinese medicine composition |
| CN104324136A (en) * | 2014-11-14 | 2015-02-04 | 马朝栋 | Traditional Chinese medicine unguent for treating osteoproliferation and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100409877C (en) | 2008-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106214752A (en) | One treats traumatic injury, fracture Chinese medicine composition and preparation method thereof | |
| CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN102526482A (en) | Traditional Chinese medicine preparation for treating lumbar disc herniation | |
| CN100409877C (en) | Chinese medicine preparation for treating hyperosteogeny | |
| CN1478525A (en) | Medicated wine for treating traumatic injury | |
| CN101554449B (en) | Traditional Chinese medicine for traumatic curing | |
| CN108498617A (en) | Rheumatalgia Chinese medicine composition and its preparation method and application, lavipeditum packet and preparation method thereof and pharmaceutical preparation | |
| CN101066307A (en) | Burn treating medicine powder and its prepn | |
| CN103230535A (en) | Medicinal liquor with function of activating collaterals to ease pain | |
| CN1969959A (en) | Externally applied medicament for treating bone fracture | |
| CN103040940A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN1435223A (en) | Externally applied medicinal stasis-and swelling-eliminating powder for treating chronic pelvic inflammation | |
| CN105616669A (en) | Traditional Chinese medicine preparation for treating traumatic injury, soft tissue injury and bone fracture and preparation method of traditional Chinese medicine preparation | |
| CN105031554A (en) | Orally-taken medicine for treating gastric ulcer | |
| CN1772148A (en) | Bone setting and hourishing capsule and its prepn process | |
| CN1243565C (en) | Traditional Chinese medicine pain-relieving bag | |
| CN110420305B (en) | Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof | |
| CN103055246A (en) | Bone impediment pain-eliminating pill | |
| CN101152329A (en) | Medicament for treating flab pain | |
| CN1164324C (en) | Chiese medicine preparation for treating parenchyma pain | |
| CN103877348A (en) | Traditional Chinese medicine preparation for treating periostitis and preparation method thereof | |
| CN103356965A (en) | Drug for curing rheumatoid arthritis | |
| CN103417700A (en) | Drug for treatment of eczema and preparation method thereof | |
| CN103736053A (en) | Steaming therapy medicament for treating lumbocrural pain and lumbar disc herniation | |
| CN1857577A (en) | Chinese medicine preparation for treating old wound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080813 Termination date: 20091116 |